Type 1 Diabetes Treatment Disappoints in Trial (HealthDay)
HealthDay – WEDNESDAY, Feb. 1 (HealthDay News) — The latest trial of a drug
called GAD-alum to treat type 1 diabetes failed to show any significant
improvement in the common markers of the blood sugar disease.